SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-16-105851
Filing Date
2016-03-17
Accepted
2016-03-17 16:03:28
Documents
7
Effectiveness Date
2016-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 a16-6756_1s8.htm S-8 127794
2 EX-5.1 a16-6756_1ex5d1.htm EX-5.1 9719
3 EX-23.1 a16-6756_1ex23d1.htm EX-23.1 3711
4 EX-99.5 a16-6756_1ex99d5.htm EX-99.5 169271
5 EX-99.6 a16-6756_1ex99d6.htm EX-99.6 82721
6 EX-99.7 a16-6756_1ex99d7.htm EX-99.7 59302
7 GRAPHIC g67561kgi001.jpg GRAPHIC 1994
  Complete submission text file 0001104659-16-105851.txt   456507
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-210255 | Film No.: 161512567
SIC: 2834 Pharmaceutical Preparations